Know Your Cost of Goods for Your Therapeutic Product and Process Development
While product Quality is always number one, an overlooked component of bringing a RegMed therapeutic to market is early consideration of final product cost, including hidden costs - which can have a major impact on both clinical implementation and commercialization.
The goal of this webinar is to discuss the importance of building a strong cost model, step-by-step MSC based example, and how your model can positively impact your product and process development.
What you will learn:
How to create a process flow diagram - at relevant scale.
How to build your Bill of Materials - what to include.
Analyze for your largest cost drivers - hidden costs can emerge.
Dr. Candiello is a bioengineering expert with years of experience working at the nexus of biomaterials, biophysics, and organoid engineering. During 10+ years in academic research, he focused primarily on engineering a stem cell based vascularized islet organoid system for diabetes research as well as previous studies understanding the biophysical properties of developing interstitial tissues during his PhD in Bioengineering at the University of Pittsburgh. Prior to his PhD, Joe received his BSc from the Pennsylvania State University in Engineering Science and Mechanics, where he currently serves on the department's Industry & Professional Advisory Council. Dr. Candiello joined RoosterBio as a Field Application Scientist in 2017 before his current role as Global Product Manager helping to bring new and innovative products to the market to support MSC based therapeutics.
Dr. Lim is a stem cell bioprocessing veteran with many years of experience developing bioreactor processes and application of experimental design strategies. She is active contributor in the bioprinting community and was recognized for her initiative in developing bioprinting tools for education as founder of SE3D. Prior to that, she was an Assistant Professor in Bioengineering at Nanyang Technological University in Singapore spearheading the stem cell bioprocessing group in bone marrow and cardiac tissue engineering. Dr. Lim obtained her PhD in Chemical Engineering from Imperial College London and BSc in Chemical Engineering from University of California, Berkeley.